A comparison of stent implant versus medical treatment for severe symptomatic intracranial stenosis: a controlled clinical trial

R Mohammadian, A Pashapour, E Sharifipour… - Cerebrovascular …, 2012 - karger.com
Background: Atherosclerotic stenosis of the major intracranial arteries is the most common
cause of ischemic stroke. There are limited treatments for severe intracranial stenosis, and …

Stenting versus medical treatment for severe symptomatic intracranial stenosis

CW Tang, FC Chang, CM Chern… - American journal …, 2011 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Intracranial atherosclerosis is especially prevalent in
Asians, but intracranial stent placement and medical treatment for severe intracranial …

Comparison of stent versus medical therapy for symptomatic patients with intracranial atherosclerotic stenosis: a meta-analysis

Q Zhang, K Dong, H Song - Journal of the Neurological Sciences, 2017 - Elsevier
Purpose To compare the outcomes of intracranial stent implantation and medical therapy for
treatment of severe intracranial stenosis. Methods Articles were identified from Medline …

A systematic review on outcome after stenting for intracranial atherosclerosis

K Gröschel, S Schnaudigel, SM Pilgram, K Wasser… - Stroke, 2009 - Am Heart Assoc
Background and Purpose—Angioplasty and stenting is increasingly being used for the
treatment of intracranial stenoses. Based on a literature search (01/1998 to 04/2008) we …

Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis–results of a single center study with 100 consecutive …

S Rohde, J Seckinger, S Hähnel… - … Journal of Stroke, 2013 - journals.sagepub.com
Background and aims Comparing safety and technical success of balloon-expandable
stents and self-expanding stents for intracranial angioplasty and stenting in medically …

Early and intermediate-term outcomes with drug-eluting stents in high-risk patientswith symptomatic intracranial stenosis

AI Qureshi, JF Kirmani, HM Hussein, P Harris-Lane… - …, 2006 - journals.lww.com
OBJECTIVE: To report the 1-month and intermediate-term results of treatment of
symptomatic intracranial stenosis using drug-eluting stents. BACKGROUND: Patients with …

Multicenter prospective trial of stent placement in patients with symptomatic high-grade intracranial stenosis

P Gao, D Wang, Z Zhao, Y Cai, T Li… - American journal …, 2016 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: On the basis of the high 1-month stroke and/or death
(14.7%) rates associated with stent placement in the Stenting versus Aggressive Medical …

Management of symptomatic intracranial arterial stenosis: Endovascular therapy

M Mazighi, A Abou-Chebl - Current atherosclerosis reports, 2006 - Springer
Patients with symptomatic intracranial stenosis are at high risk of subsequent stroke despite
the use of antithrombotic agents or surgical management. Although endovascular therapy …

Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents—initial experience

R du Mesnil de Rochemont, B Turowski, M Buchkremer… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To prospectively evaluate the safety and efficacy of undersized stents used in
patients with high-grade intracranial stenosis and recurrent ischemic symptoms who are …

Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis

OO Zaidat, AC Castonguay, BF Fitzsimmons… - Journal of stroke and …, 2013 - Elsevier
Background Patients with high-grade symptomatic intracranial stenosis (≥ 70%) have an
increased risk of recurrent stroke despite medical treatment with antiplatelet or anticoagulant …